上汽集團(600104.SH)成立商用車智能駕駛科創公司 推動自動駕駛商業化應用
上汽集團(600104.SH)宣佈,正式成立商用車智能駕駛科創公司「上海友道智途科技公司」,並計劃落戶上海自由貿易試驗區臨港新片區。
該公司將以港口、廠區等特定場景作爲L4級自動駕駛技術的應用切入點,L3級自動駕駛產品則計劃通過幹線物流場景進行落地。
集團並擬與上港集團、恆旭投資共同設立基金。該基金認繳出資總額爲6.43億元人民幣(下同)。其中,上汽集團認繳出資約5.42億元、上港集團認繳出資約1億元、恆旭資本認繳出資100萬元。基金將被用於投資商用車智能駕駛項目,暫名爲「友道智途科技」。(ta/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.